Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
J. Catella-Chatron (St-Etienne, France), A. Merah (St-Etienne, France), E. De Magalhaes (St-Etienne, France), N. Moulin (St-Etienne, France), S. Accassat (St-Etienne, France), C. Duvillard (St-Etienne, France), P. Mismetti (St-Etienne, France), L. Bertoletti (St-Etienne, France)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Catella-Chatron (St-Etienne, France), A. Merah (St-Etienne, France), E. De Magalhaes (St-Etienne, France), N. Moulin (St-Etienne, France), S. Accassat (St-Etienne, France), C. Duvillard (St-Etienne, France), P. Mismetti (St-Etienne, France), L. Bertoletti (St-Etienne, France). Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.. 3804
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: